Keli Walbert

Director

Keli Walbert is an award-winning executive with more than two decades of biopharmaceutical commercial leadership experience. Most recently, she served as executive vice president, U.S. Commercial, at Horizon Therapeutics where she was responsible for driving commercial strategy and organizational development for more than 10 marketed brands across nephrology, ophthalmology, and rare disease, among other therapeutic areas. Prior to this position, Keli held numerous roles of increasing responsibility at Horizon, including leading the launch of the blockbuster medicine TEPEZZA. She also held leadership roles at AbbVie, American Medical Association, Abbott, and United Healthcare. Keli has received numerous awards and recognitions including the Luminary Award from the Healthcare Businesswomen’s Association and the MM+M Women of Distinction Award. She has a B.A. from the University of Louisville and a M.S. from Northwestern University.